Á lódáil...
Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)
OBJECTIVE: To elucidate the clinical impact of humanized CCR4 antibody (mogamulizumab) on adult T-cell leukemia-lymphoma (ATL), we retrospectively analyzed the clinical and pathological features and treatment outcomes of aggressive ATL. METHODS: Twenty-two patients (median age: 65 years) with aggres...
Na minha lista:
| Foilsithe in: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
The Japanese Society of Internal Medicine
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709313/ https://ncbi.nlm.nih.gov/pubmed/30996180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2513-18 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|